Download the F-CRIN leaflet (976.4 ko)
The French component of the European Clinical Research Infrastructure Network (ECRIN), the F-CRIN platform (French Clinical Research Infrastructure Network), is one of the winners of the 2010 "National biology and health infrastructures" call for projects launched by the French National Research Agency (ANR) as part of the Big Loan "Future Investments" program in France. By bringing together all public and private clinical research stakeholders within a single platform, F-CRIN seeks to boost French competitiveness on the international stage by initiating and conducting major multinational clinical trials.
The F-CRIN platform aims to support researchers and promoters by helping them to meet the new international criteria concerning appeal and effectiveness. By strengthening France's impact in the European ECRIN network, F-CRIN also increases its ability to initiate major multinational clinical trials.
F-CRIN uses joint tools whose potential it reinforces:
F-CRIN involves major clinical research operators – whether they are public, such as universities, Inserm and hospital representations, or private like the ARIIS, the Alliance for Research and Innovation in Health Industries. The involvement of universities represented by their association is proof of their interest in clinical research and the participation of their teaching hospital staff.
F-CRIN will step up French competitiveness in targeted fields of high scientific value-added:
Eight work packages have been formed that, by working in a coordinated fashion, should have a positive impact on the ability of the most structured French clinical research to exist at European and international level.
These work packages, each coordinated by one or more clinical research experts, are divided into three groups:
The F-CRIN calendar for action runs over a ten-year period. F-CRIN must act as a driver enabling French clinical research to gain more visibility, become more in demand and therefore gain more recognition at European and international level.